Also known as: Hormonal therapy - breast cancer, Hormone treatment - breast cancer, Endocrine therapy, Hormone-sensitive cancers-therapy, ER positive-therapy or Aromatase inhibitors-breast cancer
- By blocking the estrogen from acting on cancer cells
- By lowering estrogen levels in a woman's body
- Taking Tamoxifen for 5 years after breast cancer surgery cuts the chance of cancer coming back by half. Some studies show that taking it for 10 years may work even better.
- It reduces the risk that cancer will grow in the other breast.
- It slows the growth and shrinks cancer that has spread.
- It reduces the risk of getting cancer in women who are high risk.
- Toremifene (Fareston)
- Fulvestrant (Faslodex)
- Anastrozole (Arimidex)
- Letrozole (Femara)
- Exemestane (Aromasin)
- Surgery to remove the ovaries
- Radiation to damage the ovaries so they no longer function, which is permanent
- Drugs such as goserelin (Zoladex) and leuprolide (Lupron) that temporarily stop the ovaries from making estrogen
- Hot flashes
- Night sweats
- Vaginal dryness
- Mood swings
- Loss of interest in sex
- Tamoxifen, blood clots, stroke, cataracts, endometrial and uterine cancers, mood swings, depression, and loss of interest in sex
- Aromatase inhibitors, high cholesterol, heart attack, bone loss, joint pain, mood swings, and depression
- Fulvestrant, loss of appetite, nausea, vomiting, constipation, diarrhea, stomach pain, weakness, and pain
Hormone therapy to treat breast cancer uses drugs or treatments to lower levels or block the action of female sex hormones (estrogen and progesterone) in a woman's body. This helps slow the growth of many breast cancers.
Hormone therapy makes cancer less likely to return after breast cancer surgery. It also slows the growth of breast cancer that has spread to other parts of the body.
Hormone therapy can also be used to help prevent cancer in women at high risk for breast cancer.
It is different from hormone therapy to treat menopause symptoms.
Hormones and Breast Cancer
The hormones estrogen and progesterone make some breast cancers grow. They are called hormone-sensitive breast cancers. Most breast cancers are sensitive to hormones.
Estrogen and progesterone are produced in the ovaries and other tissues such as fat and skin. After menopause, the ovaries stop producing these hormones. But the body continues to make a small amount.
Hormone therapy only works on hormone-sensitive cancers. To see if hormone therapy may work, doctors test a sample of the tumor that has been removed during surgery to see if the cancer might be sensitive to hormones.
Hormone therapy can work in two ways:
Drugs That Block Estrogen
Some drugs work by blocking estrogen from causing cancer cells to grow.
Tamoxifen (Nolvadex) is a drug that prevents estrogen from telling cancer cells to grow. It has a number of benefits:
Other drugs that work in a similar way are used to treat advanced cancer that has spread:
Drugs That Lower Estrogen Levels
Some drugs, called aromatase inhibitors (AIs), stop the body from making estrogen in tissues such as fat and skin. But, these drugs do not work to make the ovaries stop making estrogen. For this reason, they are used mainly to lower estrogen levels in women who have been through menopause (postmenopausal). Their ovaries no longer make estrogen.
Premenopausal women can take AIs if they are also taking drugs that stop their ovaries from making estrogen.
Aromatase inhibitors include:
Lowering Estrogen Levels From the Ovaries
This type of treatment only works in premenopausal women who have functioning ovaries. It can help some types of hormone therapy work better. It is also used to treat cancer that has spread.
There are three ways to lower estrogen levels from the ovaries:
Any of these methods will put a woman into menopause. This causes symptoms of menopause:
Drug Side Effects
The side effects of hormone therapy depend on the drug. Common side effects include hot flashes, night sweats, and vaginal dryness.
Some drugs can cause less common but more serious side effects for the different drugs include, such as:
Weighing the Options
Deciding on hormonal therapy for breast cancer can be a complex and even difficult decision. The type of therapy you receive may depend on whether you have gone through menopause before treatment for breast cancer. It also may depend on whether you want to have children. Talking with your health care provider about your options and the benefits and risks of each treatment can help you make the best decision for you.
American Cancer Society. Hormone Therapy for Breast Cancer. www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-treating-hormone-therapy. Accessed August 31, 2015.
American Society for Clinical Oncology. Hormone Therapy for Hormone Receptor-Positive Breast Cancer. www.cancer.net/research-and-advocacy/asco-care-and-treatment-recommendations-patients/hormonal-therapy-hormone-receptor-positive-breast-cancer. Accessed August 31, 2015.
Harold J. Burstein, Sarah Temin, Holly Anderson, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. J Clin Oncol. 2014 May 27.
National Cancer Institute. Hormone Therapy for Breast Cancer. www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet. Accessed August 31, 2015.
- Review date:
- December 07, 2016
- Reviewed by:
- Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.